Alterations of DNA Repair in Melanoma Cell Lines Resistant to Cisplatin, Fotemustine, or Etoposide
- 1 January 2000
- journal article
- Published by Elsevier BV in Journal of Investigative Dermatology
- Vol. 114 (1), 34-39
- https://doi.org/10.1046/j.1523-1747.2000.00844.x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Expression of DNA repair proteins hMSH2, hMSH6, hMLH1,O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistanceInternational Journal of Cancer, 1999
- Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumoursCurrent Biology, 1999
- The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells.British Journal of Cancer, 1998
- A novel plasmid shuttle vector for the detection and analysis of microsatellite instability in cell linesMutation Research/DNA Repair, 1998
- Intraarterial O 6 -benzylguanine enables the specific therapy of nitrosourea-resistant intracranial human glioma xenografts in athymic rats with 1,3-bis(2-chloroethyl)-1-nitrosoureaCancer Chemotherapy and Pharmacology, 1997
- The Chloroethylnitrosoureas: Sensitivity and Resistance to Cancer Chemotherapy at the Molecular LevelCancer Investigation, 1997
- Differential formation and enhanced removal of specific cisplatin–DNA adducts in two cisplatin-selected resistant human testicular teratoma sublinesAnti-Cancer Drugs, 1994
- Host cell reactivation of cisplatin-damaged plasmid DNA in human non-T leukocyte cell linesCancer Letters, 1992
- EtoposideDrugs, 1990
- Modulation of nitrosourea resistance in myeloid leukemiasBlood, 1988